Development Level

Tbio 12 | 11,445
Tclin 4 | 613
Tdark 2 | 6,588
Tchem 1 | 1,598

IMPC Phenotype

abnormal gait 1 | 69
decreased mean corpuscular vol... 1 | 79
enlarged lymph nodes 1 | 37
impaired righting response 1 | 26
increased lymphocyte cell numb... 1 | 32
increased neutrophil cell numb... 1 | 46

Disease

Carcinoma 10 | 11,493
Cancer 8 | 2,499
medulloblastoma, large-cell 6 | 6,241
osteosarcoma 6 | 7,950
ovarian cancer 6 | 8,520
psoriasis 6 | 6,694
Hepatitis 5 | 67
Hepatitis C 5 | 94
Hepatitis B 4 | 108
Influenza 4 | 142
Kidney cancer 4 | 2,613
Multiple Sclerosis 4 | 540
Polycythemia vera 4 | 27
Rheumatoid arthritis 4 | 1,191
glioblastoma 4 | 5,792
group 4 medulloblastoma 4 | 1,855
pancreatic cancer 4 | 2,398
Anemia 3 | 365
Diarrhea 3 | 253
Encephalitis 3 | 64
Hypersensitivity reaction type II disease 3 | 253
Liver Cirrhosis 3 | 181
Microphthalmia with limb anomalies 3 | 40
Multiple myeloma 3 | 1,332
Thrombocytopenia 3 | 197
atypical teratoid / rhabdoid tumor 3 | 5,112
cutaneous lupus erythematosus 3 | 1,057
ependymoma 3 | 4,679
lung cancer 3 | 4,740
pancreatic carcinoma 3 | 562
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
Arthritis, Rheumatoid 2 | 174
Astrocytoma, Pilocytic 2 | 3,081
Autosomal recessive predisposition 2 | 1,442
Chronic hepatitis C 2 | 12
Chronic type B viral hepatitis 2 | 2
Cryoglobulinemia 2 | 18
Hepatitis D 2 | 10
Immune system cancer 2 | 140
Immunologic Deficiency Syndromes 2 | 113
Leukopenia 2 | 72
Lymphoid leukemia 2 | 160
Melanoma 2 | 711
Mucositis 2 | 29
Pancreatic Neoplasm 2 | 85
Pancreatic Neoplasms 2 | 85
Pick disease 2 | 1,894
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 | 25
Recurrent mycobacterial infections 2 | 7
Recurrent respiratory infections 2 | 141
Relapsing remitting multiple sclerosis 2 | 14
Renal Cell Carcinoma 2 | 214
Severe acute respiratory syndrome 2 | 27
Stomatitis 2 | 21
Systemic lupus erythematosus 2 | 194
Thyroiditis 2 | 29
dermatomyositis 2 | 966
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
juvenile dermatomyositis 2 | 1,187
malignant mesothelioma 2 | 3,232
tuberculosis 2 | 2,010
Achondroplasia 1 | 21
Aicardi-Goutieres syndrome 1 | 19
Anti-nuclear factor positive 1 | 18
Autoimmune hemolytic anemia 1 | 31
Biliary cirrhosis 1 | 45
Biopsy shows villous atrophy 1 | 16
C-reactive protein increased 1 | 15
Crimean-Congo hemorrhagic fever 1 | 9
Duodenal villous atrophy 1 | 16
ESR raised 1 | 20
Elevated C-reactive protein level 1 | 15
Elevated IgE 1 | 10
Enterocolitis 1 | 8
Hairy Cell Leukemia 1 | 5
Hepatitis, Chronic 1 | 23
Hepatosplenomegaly 1 | 22
Herpes simplex 1 | 18
Intestinal perforation 1 | 7
Iridocyclitis 1 | 19
Job's syndrome 1 | 3
Joint swelling 1 | 26
Juvenile rheumatoid factor-negative polyarthritis 1 | 9
Liver Cirrhosis, Biliary 1 | 33
Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 | 2
Lymphomatoid Papulosis 1 | 2
Oligoarticular juvenile arthritis 1 | 9
Paranoia 1 | 20
Pauciarticular juvenile rheumatoid arthritis 1 | 9
Polyarthritis 1 | 11
Recurrent fungal infections 1 | 13
Recurrent viral infections 1 | 15
Small intestine biopsy shows villous atrophy 1 | 16
Subacute sclerosing panencephalitis 1 | 11
Susceptibility to viral and mycobacterial infections 1 | 11
Thanatophoric dysplasia 1 | 7
Tyrosine Kinase 2 Deficiency 1 | 1
Variable degree of villous atrophy 1 | 16
Villous atrophy 1 | 16
Villous atrophy of intestine 1 | 16

Tissue

Blood and immune system 9 | 16,909
Male tissues 9 | 17,142
Nervous System 8 | 16,725
Urinary Tract 8 | 16,678
Cardiovascular System 7 | 15,192
Digestive Tract 7 | 17,369
Endocrine System 7 | 18,159
Female tissues 7 | 17,400
Liver and Pancreas 7 | 16,750
Respiratory system 7 | 16,393
Skin and soft tissues 7 | 17,230

Target Family

Non-IDG 14 | 12,091
Transcription Factor 3 | 1,400
Kinase 2 | 634

PathwayCommons: inoh Pathway

http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 236 | 236
http://pathwaycommons.org/pc2/... 235 | 235
http://pathwaycommons.org/pc2/... 233 | 233
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 183 | 183
http://pathwaycommons.org/pc2/... 178 | 178
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 123 | 123
http://pathwaycommons.org/pc2/... 96 | 96
http://pathwaycommons.org/pc2/... 85 | 85
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 60 | 60
http://pathwaycommons.org/pc2/... 58 | 58
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 55 | 55
http://pathwaycommons.org/pc2/... 51 | 51
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 44 | 44
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 34 | 34
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 28 | 28
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 22 | 22
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 15 | 15

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interferon alpha-1/13 IFNA13 Tbio Non-IDG -3.87160 7663.4 500
Interferon alpha-17 IFNA17 Tbio Non-IDG -2.39299 231.1 56
Interferon alpha-6 IFNA6 Tbio Non-IDG -0.90731 7.40 134
Interferon alpha-16 IFNA16 Tdark Non-IDG -0.26324 1.39 73
Signal transducer and activator of transcription 2 STAT2 Tbio Transcription Factor -2.43127 248.8 691
Non-receptor tyrosine-protein kinase TYK2 TYK2 Tclin Kinase -2.47105 252.9 547
Interferon alpha-2 IFNA2 Tbio Non-IDG -3.39500 2358.5 793
Interferon alpha-14 IFNA14 Tbio Non-IDG -0.36715 2.01 72
Interferon alpha-5 IFNA5 Tbio Non-IDG -1.78970 53.6 150
Interferon alpha-21 IFNA21 Tbio Non-IDG -0.88029 5.87 91